Literature DB >> 2844848

Remarkably homogeneous population of adenovirus type 3 and 7 genome types.

M Arens1, V Dilworth.   

Abstract

A total of 270 frozen adenovirus isolates, obtained from January 1981 to December 1986, were grown in KB cells. DNA was successfully prepared from 248 of these isolates, and the prepared DNA was digested initially with SmaI restriction endonuclease and then analyzed by agarose gel electrophoresis. Restriction fragment patterns showed that 68 of these DNAs were either adenovirus type 3 (Ad3) or Ad7. Further analysis by digestion with BamHI showed that 24 isolates were Ad3a and 44 isolates were Ad7b. When Ad3 isolates were digested with SmaI or PstI, the restriction fragment patterns of the 24 isolates were identical. Of these 24 isolates, 20 (83%) also gave identical patterns when digested with HindIII, and the patterns of the remaining 4 isolates were different from that of the 20 but identical to each other. All Ad3 isolates were obtained in 1982, 1983, and 1986. All the 44 Ad7b isolates gave identical fragment patterns when digested with BglI or PvuII, and 43 of 44 (98%) isolates gave identical patterns when digested with SstII. We obtained at least two Ad7 isolates during each of the 6 years studied. Although considerable genome heterogeneity within adenovirus serotypes and subtypes has been reported, our population of isolates is remarkably homogeneous. This homogeneous set of genome types was obtained from diverse anatomical sites and was associated with a broad spectrum of clinical syndromes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844848      PMCID: PMC266674          DOI: 10.1128/jcm.26.8.1604-1608.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Examination of uncommon clinical isolates of human adenoviruses by restriction endonuclease analysis.

Authors:  G W Hammond; G Mauthe; J Joshua; C K Hannan
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

2.  Genetic heterogeneity of recent isolates of adenovirus types 3, 4, and 7.

Authors:  A S Bailey; S J Richmond
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

3.  Molecular epidemiology of human adenoviruses.

Authors:  G Wadell
Journal:  Curr Top Microbiol Immunol       Date:  1984       Impact factor: 4.291

4.  The changing etiology of epidemic keratoconjunctivitis: antigenic and restriction enzyme analyses of adenovirus types 19 and 37 isolated over a 10-year period.

Authors:  M C Kemp; J C Hierholzer; C P Cabradilla; J F Obijeski
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

5.  Isolation and characterization of six new genome types of human adenovirus types 1 and 2.

Authors:  K H Fife; R Ashley; L Corey
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

6.  Molecular epidemiology of adenoviruses: global distribution of adenovirus 7 genome types.

Authors:  G Wadell; M K Cooney; A da Costa Linhares; L de Silva; M L Kennett; R Kono; R Gui-Fang; K Lindman; J P Nascimento; B D Schoub
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

7.  Molecular epidemiology of adenoviruses: alternating appearance of two different genome types of adenovirus 7 during epidemic outbreaks in Europe from 1958 to 1980.

Authors:  G Wadell; J C de Jong; S Wolontis
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

8.  A proposal for naming adenovirus genome types, exemplified by adenovirus type 6.

Authors:  T Adrian; B Best; R Wigand
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

9.  Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome.

Authors:  C D Brandt; H W Kim; A J Vargosko; B C Jeffries; J O Arrobio; B Rindge; R H Parrott; R M Chanock
Journal:  Am J Epidemiol       Date:  1969-12       Impact factor: 4.897

  9 in total
  9 in total

Review 1.  Methods for subtyping and molecular comparison of human viral genomes.

Authors:  M Arens
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Genome type analysis of 480 isolates of adenovirus types 1, 2, and 5.

Authors:  T Adrian; J Sassinek; R Wigand
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Changes in subgenome types of adenovirus type 4 isolated from patients with ocular disease between 1985 and 1989 in Sapporo, Japan.

Authors:  S Itakura; K Aoki; H Sawada; N Ishiguro; M Shinagawa
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

4.  Genome analysis of adenovirus type 3 isolated in Japan.

Authors:  S Shiao; K Aoki; K Isobe; W L Tsuzuki; N Itoh; K Toba; N Kobayashi; Y Noguchi; S Ohno
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Analysis with restriction endonucleases recognizing 4- or 5-base-pair sequences of human adenovirus type 3 isolated from ocular diseases in Sapporo, Japan.

Authors:  S Itakura; K Aoki; H Sawada; M Shinagawa
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

6.  New genome types of adenovirus types 1, 3, and 5 isolated from stools of children in Brazil.

Authors:  S A Gomes; J A Candeias; S P Monteiro; H G Pereira; C Niel
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

7.  Sensitive analysis of genetic heterogeneity of adenovirus types 3 and 7 in the Soviet Union.

Authors:  G I Golovina; F N Zolotaryov; T I Yurlova
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

8.  Emergent US adenovirus 3 strains associated with an epidemic and serious disease.

Authors:  Mark G Lebeck; Troy A McCarthy; Ana W Capuano; David P Schnurr; Marie L Landry; Sharon F Setterquist; Gary L Heil; Selim Kilic; Gregory C Gray
Journal:  J Clin Virol       Date:  2009-10-23       Impact factor: 3.168

9.  Adenovirus type 3 outbreak in connecticut associated with a novel variant.

Authors:  Marie L Landry; Mark G Lebeck; Ana W Capuano; Troy McCarthy; Gregory C Gray
Journal:  J Med Virol       Date:  2009-08       Impact factor: 2.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.